Clinical trial

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT06851663

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-12-23

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2024-12-23Date precision: day

Registry last updated2026-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Tumorunresolved

Solid Carcinomaunresolved

Uroepithelial Carcinomaunresolved

Bladder Cancerunresolved

Prostate Cancerunresolved

Lung Cancerunresolved

Nasopharyngeal Cancerunresolved

Liver Cancerunresolved

Cholangiocarcinomaunresolved

Ovarian Cancerunresolved

Cervical Cancerunresolved

Endometrial Cancerunresolved

Thyroid Cancerunresolved

Head and Neck Cancerunresolved

Interventions

[68Ga]Ga-NOTA-T4DRUG

[68Ga]Ga-NOTA-RT4DRUG

[18F]F-RESCA-T4DRUG

[18F]F-RESCA-RT4DRUG

Sponsors & collaborators

RenJi Hospitallead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06851663 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.